Early-stage molecular diagnostics company NuProbe raised $11 million to continue development of its non-invasive blood test for the early detection of cancer and infectious diseases. The Series A funding was co-led by Sequoia China and Serica Partners, with additional investor WuXi AppTec Corporate Ventures. Developed